ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,967, issued on June 9, was assigned to Wake Forest University Health Sciences (Winston-Salem, N.C.), Emory University (Atlanta) and Children's Healthcare of Atlanta Inc. (Atlanta).
"Post-natal transplantation of factor VIII-expressing cells for treatment of hemophilia" was invented by Maria Graca N.D. Almeida-Porada (Winston-Salem, N.C.), Christopher D. Porada (Winston-Salem, N.C.), Anthony Atala (Winston-Salem, N.C.), Christopher B. Doering (Atlanta) and H. Trent Spencer (Marietta, Ga.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are method of treating hemophilia A in a subject comprising injecting the subject with mesenchymal str...